Advertisement

Topics

Merck KGaA (MRK) Given a 105.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts

04:19 EDT 21 Aug 2017 | Topix

The brokerage currently has a neutral rating on the healthcare company's stock. MRK has been the subject of a number of other reports.

Original Article: Merck KGaA (MRK) Given a 105.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts

NEXT ARTICLE

More From BioPortfolio on "Merck KGaA (MRK) Given a 105.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...